Literature DB >> 17141069

Changes in treatment of advanced laryngeal cancer 1985-2001.

Amy Y Chen1, Nicole Schrag, Yongping Hao, W Dana Flanders, James Kepner, Andrew Stewart, Elizabeth Ward.   

Abstract

OBJECTIVE: In 1991, a randomized study was published and demonstrated that use of nonsurgical therapy (chemoradiation) provided similar survival to total laryngectomy (the gold standard) for patients with advanced-stage laryngeal cancer. The purpose of this study was to assess how treatment of advanced laryngeal cancer was influenced by such developments in non-surgical therapy. STUDY
DESIGN: Patterns of care study using National Cancer Database (1985-2001).
RESULTS: The percentage of advanced-stage patients treated with chemoradiation increased from 8.3% to 20.8% while the proportion treated with radiation alone decreased from 38.9% to 23.0%. Use of chemoradiation increased at a significantly faster rate after the 1991 publication at both community cancer centers and teaching research facilities. The use of total laryngectomy decreased slightly during this period.
CONCLUSIONS: The use of chemoradiation increased after the 1991 publication. It was impossible to determine from the NCDB whether additional patients who could benefit from chemo-RT were not offered or did not complete this treatment option. We recommend that treatment recommendations discussed at tumor boards be recorded in cancer registries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141069     DOI: 10.1016/j.otohns.2006.07.012

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  14 in total

Review 1.  Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers.

Authors:  Katherine A Hutcheson; Jan S Lewin
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

2.  Secular trends in the survival of patients with laryngeal carcinoma, 1995-2007.

Authors:  S D MacNeil; K Liu; S Z Shariff; A Thind; E Winquist; J Yoo; A Nichols; K Fung; S Hall; A X Garg
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

3.  Quality initiatives in head and neck cancer.

Authors:  Amy Y Chen
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

4.  Complications, hospital length of stay, and readmission after total laryngectomy.

Authors:  Ryan P Goepfert; Katherine A Hutcheson; Jan S Lewin; Neha G Desai; Mark E Zafereo; Amy C Hessel; Carol M Lewis; Randal S Weber; Neil D Gross
Journal:  Cancer       Date:  2016-12-27       Impact factor: 6.860

Review 5.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

6.  Prevalence and associated factors of aspiration and severe dysphagia in asymptomatic patients in the late period after open partial laryngectomy: a videofluoroscopic evaluation.

Authors:  Andressa Silva de Freitas; Izabella C Santos; Cristina Furia; Rodrigo Dornelas; Ana Catarina Alves E Silva; Fernando Luiz Dias; Gil F Salles
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-04       Impact factor: 2.503

7.  Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.

Authors:  Gorkem Eskiizmir; Gokce Tanyeri Toker; Onur Celik; Kivanc Gunhan; Ayca Tan; Hulya Ellidokuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

8.  Treatment complications and survival in advanced laryngeal cancer: a population-based analysis.

Authors:  Caitriona B O'Neill; James P O'Neill; Coral L Atoria; Shrujal S Baxi; Martin C Henman; Ian Ganly; Elena B Elkin
Journal:  Laryngoscope       Date:  2014-10-04       Impact factor: 3.325

9.  Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.

Authors:  Clifton D Fuller; Abdallah S R Mohamed; Adam S Garden; G Brandon Gunn; Collin F Mulcahy; Mark Zafereo; Jack Phan; Stephen Y Lai; Jan S Lewin; Katherine A Hutcheson; Steven J Frank; Beth M Beadle; William H Morrison; Adel K El-Naggar; Esengul Kocak-Uzel; Lawrence E Ginsberg; Merril S Kies; Randal S Weber; David I Rosenthal
Journal:  Head Neck       Date:  2016-07-28       Impact factor: 3.147

10.  Evaluation of the revised TNM classification in advanced laryngeal cancer.

Authors:  G Psychogios; F Waldfahrer; A Bozzato; H Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.